Maegim

Stock search

Search by company name, 6-digit code, or Korean initials (e.g. ㅅㅅㅈㅈ)

한국어

DreamCIS INC.

드림씨아이에스223250KOSDAQSector: Pharma & Biotech
₩3,4100.00%Market cap ₩83.9BAs of Sep 1, 2026 close · updated once daily
Market cap
₩83.9B
#806 in KOSDAQ
11.8x
Sector median 16.3x (profitable cos.)
1.10x
Sector median 1.61x
0.0%
Sector median 0.0%
B
Grade B60.9 ptsTop 31% of 2,523 graded stocksMethodology v2.0

As of Sep 1, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

How to read this grade
SABCurrentCDF

Toward S means a higher total-score band; toward F, a lower band. Badges are distinguished by ink intensity and shape (fill, outline, dashed) — never by hue.

Maegim maps a total score — built from sector-relative percentile scoring — onto fixed, predefined thresholds to assign one of six bands, S to F. This stock is scored by the same formula as all 2,523 graded stocks and is currently in band B with a total score of 60.9 points.

Position within sector

Mechanically selected indicators in the top or bottom 30% of sector percentiles · among 250 stocks in Pharma & Biotech

1-year closing price

Loading closing price history…
 
Low ₩2,450High ₩7,690
Latest close
Price change by period
1W
2.10%
1M
20.40%
3M
26.10%
1Y
0.40%

As of the Sep 1, 2026 close · updated once daily · a factual record computed from closing prices only; dividends are not included, and this is not a buy or sell signal.

1

Financial strength

54.2/100
How much debt does it carry relative to equity?
88.6%
Sector median 51.6%
Sector lowhighBottom 28.5% in sector
Can it cover what's due within a year?
107.6%
Sector median 191.7%
Sector lowhighBottom 24.9% in sector
How much of revenue becomes profit?
7.9%
Sector median -2.4%
Sector lowhighTop 22.3% in sector
How much did it earn on its own capital?
9.3%
Sector median -4.5%
Sector lowhighTop 14.4% in sector

Source filing: annual report (consolidated) — view original

2

Growth momentum

61.2/100
How much did revenue grow in a year?
13.6%
Sector median 6.4%
Sector lowhighTop 33.4% in sector
Has it grown steadily over three years?
19.7%
Sector median 4.9%
Sector lowhighTop 13.5% in sector
Did core profits grow in a year?
3.6%
Sector median 3.6%
Sector lowhighTop 50% in sector
Are core profits higher than three years ago?
-10.0%
Sector median 3.5%
Sector lowhighBottom 41.7% in sector

Financial trend

Revenue

Growth & margin

Revenue growth Operating margin

Year over year — alongside the sector median

This stock Sector median

A factual chart of confirmed annual results from annual reports — the same source as the grading indicators. Not a buy or sell signal.

Source filing: annual report (consolidated) — view original

3

Price attractiveness

71.9/100
Is the price expensive relative to earnings?
11.8x
Sector median P/E of profitable peers 16.3x · 58% loss-making
Sector lowhighTop 16.4% in sector
Is the price expensive relative to book value?
1.10x
Sector median 1.61x
Sector lowhighTop 39.9% in sector

Valuation uses the Sep 1, 2026 close and market cap

4

Shareholder Return

Single-indicator axis37.5/100
Does the company actually pay dividends?
0.0%
Sector median 0.0%
Sector lowhighBottom 37.5% in sector

Source filing: annual report (consolidated) — view original

Financial checklist

Based on the FY2025 annual report · year-over-year comparison · determined on Sep 2, 2026

Of 9 items: 5 met · 4 not met · 0 not computable

Not metMetNot computable

Positive net income
Whether net income (attributable to owners where available) is above zero.
Met
₩7.1B
Positive operating cash flow
Whether cash flow from operations is above zero.
Met
₩14.1B
Return on assets up
Whether net income over beginning total assets rose from the prior year.
Met
5.96% → 6.01%
Operating cash flow exceeds net income
Whether operating cash flow is greater than net income.
Met
₩14.1B vs ₩7.1B
Liabilities-to-assets ratio down
Whether total liabilities as a share of total assets fell from the prior year.
Not met
35.4% → 47.0%
Current ratio up
Whether current assets over current liabilities rose from the prior year.
Not met
171.7% → 107.6%
Shares outstanding not increased
Whether common shares issued did not increase from the prior year. Increases from bonus issues and stock dividends are also counted.
Met
23,799,324 → 23,799,324
Operating margin up
Whether operating income over revenue rose from the prior year.
Not met
8.6% → 7.9%
Asset turnover up
Whether revenue over beginning total assets rose from the prior year.
Not met
0.66x → 0.56x

A record of facts determined by fixed rules from the financial statements in the latest annual report. Not used in grading, and not a buy or sell signal. Source filing: annual report (consolidated) — view original

Grade change history

Jul 23, 2026B

Methodology version change (v2.0 applied)

Jul 15, 2026BVersion v1

First calculation

Grade changes are a factual record produced from public data by a fixed formula; they do not signal future changes.

Disclosure & financial badges

Factual records determined from public filings and periodic reports by fixed rules — not buy/sell signals.

Negative-evidence group (dilution, loss, dispute)Mixed interpretationPositive-evidence group (shareholder return)Dots classify the disclosure type by the direction of research evidence — not an assessment or investment judgment about this company.

Disclosure event history

CB with conversion-price adjustment clause (past 36 months)

1 convertible bond (CB) issuance resolutions including a downward conversion-price adjustment (refixing) clause were disclosed in the past 36 months (latest filing 2025-09-22). View filing

Largest-shareholder changes (past 36 months)

The largest shareholder changed 2 times in the past 36 months (latest change 2024-05-16, per annual report).

Determined as of 2026-09-02

Recent filings for this stock

Last 120 days · monitored filing types only
Periodic report filedAug 13, 2026Source
Periodic report filedMay 14, 2026Source

View in the filings calendar →